Generation Bio(GBIO) - 2024 Q4 - Annual Results
Generation Bio(GBIO)2025-03-13 20:10Exhibit 99.1 Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2024 Financial Results CAMBRIDGE, MASS., Mar. 13, 2025 -- Generation Bio Co. (Nasdaq:GBIO), a biotechnology company working to change what's possible for people living with T cell-driven autoimmune diseases, reported business highlights and fourth quarter and full year 2024 financial results. "Our T cell-selective lipid nanoparticle (LNP) is designed to overcome a long- standing challenge for siRNA therapeutics, which i ...